Armauer Hansen Research Institute(AHRI)


The Armauer Hansen Research Institute (AHRI) was founded in 1970 through the initiative of the Norwegian and Swedish Save the Children organizations seconded by the Ministry of Health of Ethiopia.

The Institute got its name from the Norwegian physician, Gerhard Henrik Armauer Hansen, who first described the leprosy bacillus (Mycobacterium leprae).

The Institute joined the Ethiopian Ministry of Health in 2004 and in 2016 it became a government health agency under the Council of Ministers Regulation No.376/2016.

AHRI receives core support for its research activities from Sida and Norad and enjoys tax free privileges from the Ethiopian government. Postgraduate (MSc and some PhD) theses are funded from the core budget of the institute while most of the other research is funded by competitive grants. AHRI research activities cover basic (immunology and molecular biology), epidemiological and translational research and to this end, AHRI has published more than 900 papers in peer reviewed journals so far. It has also produced several theses and dissertations from Ethiopian and international scholars in biomedical research. Furthermore, the institute has a network of national and international collaborators in peer reviewed grant projects, clinical trial partnerships, capacity building activities and in training of MSc and PhD students.


AHRI’s mission is to improve medical care by advancing the health and wellbeing of the public through; generating and delivering scientific evidence, developing new tools and methods through biomedical, clinical and translational research, and by serving as a hub for technology transfer and capacity building in medical research and training.


To be the leading medical research and training institute in Africa by 2025.

Contact Information
P.O.Box 1005
Kolfe-Keranyo, Jimma Road, ALERT campus, Addis Ababa, Ethiopia
Telephone + (251) 113483752